12:00 AM
Nov 15, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

UT-15: Completed Phase III studies enrollment

United Therapeutics Corp. (UTHR), Silver Spring, Md.
Product: UT-15
Business: Cardiovascular, Pulmonary...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >